HNGE - NYSE
Hinge Health, Inc.
$58.66
-0.20%Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
At a Glance
Live SnapshotHinge Health, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Hinge Health, Inc. Cash Flow Statement
HNGE • NYSE
| Hinge Health, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
OPERATING ACTIVITIES | |||
-528.3M | -11.9M | -108.1M | |
5.5M | 6M | 5.6M | |
53K | -585K | -473K | |
643M | 739K | 1.6M | |
53.2M | 41.3M | 28M | |
-2M | 13.5M | 9.4M | |
171.4M | 49M | -63.9M | |
INVESTING ACTIVITIES | |||
-708K | -1M | -2M | |
-4M | (0.0) | (0.0) | |
-472.3M | -324.5M | -453.3M | |
368.6M | 346.6M | 459.5M | |
-5.4M | -2.7M | -2.6M | |
-113.8M | (18.3M) | (1.5M) | |
FINANCING ACTIVITIES | |||
200.2M | 610K | 0.0 | |
-65M | (0.0) | (0.0) | |
-350.6M | -2.8M | -3M | |
-150.5M | -2.2M | -3M | |
CASH FLOW SUMMARY | |||
-92.8M | 65.1M | -65.4M | |
302.6M | 237.5M | 302.9M | |
209.8M | 302.6M | 237.5M | |
170.7M | 45.2M | -68.5M |
SEC Filings
HNGE - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 17, 2026 | June 03, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 17, 2026 | March 16, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 03, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 10, 2026 | February 10, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 12, 2025 | November 10, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 07, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 04, 2025 | November 04, 2025 | 2025 | |
8-K 8-K 2025 N/A | August 13, 2025 | August 06, 2025 | 2025 |
Related Guides
Continue your HNGE research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.